Jason W. Skudlarek

Carboxylated, Heteroaryl-Substituted Chalcones as Inhibitors of Vascular Cell Adhesion Molecule-1 Expression for Use in Chronic Inflammatory Diseases

Charles Q. Meng, Liming Ni, Kimberly J. Worsencroft et al. · Journal of Medicinal Chemistry · 2007 · 48 citations

Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-α-induced VCAM-1 expression

Charles Q. Meng, Xiaoxiang Zheng, Liming Ni et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 24 citations · Full text

Novel Heteroaryl-substituted Chalcones, Tnf-α-induced Vcam-1 Expression, Medicinal Chemistry +6

Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties

Scott D. Kuduk, Jason W. Skudlarek, Christina N. DiMarco et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 20 citations · Full text

Favorable Development Properties, Functional Selectivity, Medicine +8

Computer-Aided Design of Chiral Ligands. Part III. A Novel Ligand for Asymmetric Allylation Designed Using Computational Techniques

Marisa C. Kozlowski, Stephen P. Waters, Jason W. Skudlarek et al. · Organic Letters · 2002 · 20 citations

Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumannii

Hao Wang, Andrii Ishchenko, Jason W. Skudlarek et al. · Nature Microbiology · 2024 · 15 citations

Health Sciences, Medicine, Membrane Biology +9